Public Policy Resources

Breast cancer screening is a continuum. It begins with a screening mammogram, which is often free for most insured women.

Our latest survey finds that 31% of screening-age adults have been more than one year behind on recommended routine cancer screenings. Over half say out-of-pocket costs are a barrier to getting screened, while 47% report that getting insurance approvals for covered screenings is a barrier.

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer. 

Comprehensive tobacco retailer licensing laws can reduce the harmful impact of the tobacco retail environment by regulating where and how tobacco retailers can operate and sell tobacco products as well as providing the licensing entity the authority to ensure tobacco retailers are complying with all applicable tobacco control laws.

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

The tobacco industry has a history of using litigation to avoid and delay laws and regulations enacted to safeguard the public. ACS CAN, with our tobacco control partners, has also relied on the courts to hold Big Tobacco accountable and to ensure the federal government is effectively implementing the Tobacco Control Act.

A critical factor for eliminating disparities and ensuring health equity is the guarantee that all people have access to quality, affordable health care.

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.